ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

novartis europharm limited  - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - nilotinib - kapsula, tvrda - 150 mg/1 kapsula - 1 kapsula sadrži: 150 mg nilotiniba (u obliku nilotinibhidrohlorid, monohidrata)

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

alnylam netherlands b.v. - givosiran - Порфирий, zatajenje - različite dijelove probavnog trakta i metabolizma proizvodi - liječenje akutnog zatajenja порфирии (АХА) kod odraslih i adolescenata u dobi od 12 godina i stariji.

বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - nilotinib - kapsula, tvrda - 200 mg/1 kapsula - 1 kapsula, tvrda sadrži: 200 mg nilotiniba (u obliku nilotinibhidrohlorid, monohidrata)

বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - nilotinib - kapsula, tvrda - 200 mg/1 kapsula - jedna kapsula sadrži: 200 mg nilotiniba (u obliku hidrohlorid monohidrata)

বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - nilotinib - kapsula, tvrda - 150 mg/1 kapsula - 1 kapsula sadrži: 150 mg nilotiniba (u obliku nilotinibhidrohlorid, monohidrata)

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin меглюмина - infekcije stečene u zajednici - antibakterijski lijekovi za sistemsku primjenu, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 i 5. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.

বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

nobel lijek d.o.o. sarajevo - nilotinib - kapsula, tvrda - 150 mg/1 kapsula - jedna kapsula sadrži nilotinib hidrohlorid u količini ekvivalentnoj 150mg nilotiniba kao aktivne supstance.

বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

nobel lijek d.o.o. sarajevo - nilotinib - kapsula, tvrda - 200 mg/1 kapsula - 1 kapsula sadrži nilotinib hidrohlorid u količini ekvivalentnoj 200 mg nilotiniba kao aktivne supstance.